Anbio Biotechnology (NNNN) Equity Ratio (2023 - 2025)

Anbio Biotechnology's Equity Ratio history runs 3 years deep, the most recent figure standing at 1.0 for Q4 2025.

• In Q4 2025, Equity Ratio rose 9.74% year-over-year to 1.0; the TTM figure through Dec 2025 stood at 1.0 (up 9.74% YoY), while the FY2025 annual figure was 1.0, up 9.74% from the prior year.
• Equity Ratio was 1.0 for Q4 2025 at Anbio Biotechnology, up from 0.91 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 1.0 in Q4 2025 to a low of 0.91 in Q4 2024.
• Historically, Equity Ratio has averaged 0.95 across 3 years, with a median of 0.94 in 2023.
• The sharpest annual moves came in 2024 and 2025: Equity Ratio slipped 3.06% in 2024, then grew 9.74% in 2025.
• A 3-year view of Equity Ratio shows it stood at 0.94 in 2023, then retreated by 3.06% to 0.91 in 2024, then grew by 9.74% to 1.0 in 2025.
• The last three Equity Ratio figures came in at 1.0 (Q4 2025), 0.91 (Q4 2024), and 0.94 (Q4 2023), per Business Quant data.